CJ Turtle, LA Hanafi, C Berger, TA Gooley… - The Journal of …, 2016 - ncbi.nlm.nih.gov
BACKGROUND. T cells that have been modified to express a CD19-specific chimeric
antigen receptor (CAR) have antitumor activity in B cell malignancies; however, identification …